It was of late reported that Apple CEO and co-founder Steve Jobs had a liver transplant a little over two months ago, which was kept muted until last weekend. Though, the information about its iPhone sales spread like wildfire and was very much touted by the company. So why would the company keep the intelligence about its CEO quiet from the earth?
It matters since it looks like investors in Apple worry what is going on with Jobs health. He is the visage of the company and perceived as the major creative force behind the Apple products. He was the one who reinvigorated the company by going on and looking at what the objective market was in search of in products, he listened when it seemed like no one else would to the newest techie generation and ended up earning a lot of money for the company by taking this method. If you watch the stock prices for Apple with every little bit of sour news about Jobs fitness, you can easily tell how individuals feel about him and the amount it means if he were to depart the company in total.
In reaction to why the news about Jobs liver transplant came from the Wall Street Journal and not from Apple, businesses do not have to provide updates on the healthiness of their executives. Health is not perceived as material information as per the regulations of the SEC. Material information means information that regards earnings, mergers, and acquisitions as well as new products, bankruptcies, and items of that nature. Information such as stock ownership is material information, while the health issues of an executive is not considered material information unless his healthiness hinders his capacity to be an official in the company. Since Jobs has been on medicinal leave for the past few months, there is no issue here.
In the instance of Jobs and his liver transplant, it might have been best for the board to inform the public about his well being problems just because the majority of people feared the worst when he took a unexpected medical leave of absence in January. When he announced that, the stock for Apple shed 7% and on Monday of this week it fell an additional percentage point since of the information about his liver transplant. If investors had known about the transplant ahead of time, this drop in stock value may have simply happened at the same time the leave of absence was announced.
I suppose that Apple is afraid, without Jobs, it will no longer be seen as the business that it at present is and its stock will descend and it will lose the market portion it has worked so hard to acquire. This is a company that, previous to Jobs return years ago, was on the brink of economic failure. It is time for Apple to become a company that is at a distance from its CEO.Study more about
medical leave and find the top
Advice Investment.
